Of note, it has been shown that the CTLA-4 gene might be involved in the predisposition to MS and that a defect in CTLA-4 signaling could be implicated in the immune dysregulation that occurs in MS patients [76]. The gene discussed is CTLA4; the disease is myeloid sarcoma.